Event JSON
{
"id": "f93e540ca9f7ec8da4dc17954c88fac69f1892f3d027b41c53b114ed5428b5d2",
"pubkey": "9fe56a748acf00a2067a550ef2f72eefaa7cf292df952afd901b2ed2dfa8c883",
"created_at": 1683141721,
"kind": 1,
"tags": [
[
"p",
"62a04c04d152ef5bd7bc6e6320550fb224f0a9747e94fa17ef499ecc4cf3940f",
"wss://relay.mostr.pub"
],
[
"p",
"43faba8b2cc565cb757af10a19784bd9fddb5badc2a881edb0baadb27b1fab46",
"wss://relay.mostr.pub"
],
[
"e",
"d09209cd860a8db83644a70496b48af383281a3d3bae36fceffa0e9f3da74993",
"wss://relay.mostr.pub",
"reply"
],
[
"mostr",
"https://mstdn.social/users/walterdunham/statuses/110306375877814448"
]
],
"content": "nostr:npub1v2sycpx32th4h4aude3jq4g0kgj0p2t5062059l0fx0vcn8njs8spcmqq5 \nThe very same vaccine, Nirsevimab (generic name), was authorized in Canada on April 19. This one was by AstraZeneca and Sanofi.\n\nhttps://globalnews.ca/news/9644033/health-canada-antibody-drug-rsv/",
"sig": "2aa8c2cc616b74d7b66c0fc197dd7c80ac58e5b1606e1ac86a9124016ed16fefe4baadfd193109e7e4645f5585719209b667a43669a507ab9c3cbaf5f145f5bb"
}